NASDAQ:KRBP
Kiromic BioPharma, Inc.
- Stock
Last Close
3.08
17/05 16:41
Market Cap
1.89M
Beta: 0.16
Volume Today
11.56K
Avg: 281.88K
PE Ratio
−0.08
PFCF: −0.10
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 19.25K - | 11.10K 42.34% | |||||
average payables | 335.75K - | 558.80K 66.43% | 1.44M 157.65% | 4.76M 230.70% | 4.72M 0.82% | ||
average receivables | 12.15K - | 8.10K - | 8.10K 0% | ||||
book value per share | 2.25 - | 15.30 579.27% | 75.65 394.35% | 71.78 5.11% | -10.60 114.77% | -8.31 21.64% | |
capex per share | -1.17 - | -2.34 100.76% | -9.70 314.62% | -4.98 48.70% | -8.96 80.03% | -0.19 97.90% | |
capex to depreciation | -1.70 - | -3.46 103.84% | -7.29 110.67% | -4.03 44.66% | -2.92 27.69% | -0.09 96.81% | |
capex to operating cash flow | 0.06 - | 0.10 62.89% | 0.24 129.02% | 0.09 60.81% | 0.21 120.43% | 0.01 95.26% | |
capex to revenue | |||||||
cash per share | 3.26 - | 14.92 357.11% | 67.58 353.06% | 66.61 1.43% | 1.18 98.22% | 2.92 146.36% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.04 - | 0.01 59.45% | 0.79 5,216.52% | 1.28 62.43% | |||
debt to equity | 0.04 - | 0.02 59.61% | -1.63 9,895.40% | -1.70 4.57% | |||
dividend yield | |||||||
earnings yield | -0.09 - | -0.08 10.50% | -0.50 498.60% | -1.47 191.84% | -12.91 779.34% | -21.94 69.89% | |
enterprise value | 40.24M - | 42.69M 6.07% | 28.48M 33.28% | -7.43M 126.08% | 11.72M 257.78% | 13.29M 13.41% | |
enterprise value over ebitda | -12.97 - | -11.80 9.06% | -1.50 87.29% | 0.30 120.00% | -0.40 232.81% | -0.67 67.45% | |
ev to operating cash flow | -18.69 - | -14.65 21.63% | -4.65 68.27% | 0.37 107.86% | -0.49 235.02% | -0.63 26.87% | |
ev to sales | |||||||
free cash flow per share | -19.45 - | -24.87 27.90% | -50.50 103.02% | -58.37 15.60% | -52.57 9.94% | -19.53 62.86% | |
free cash flow yield | -0.06 - | -0.07 27.90% | -0.20 175.64% | -1.27 539.93% | -9.68 661.31% | -22.44 131.81% | |
graham net net | -1.70 - | 9.79 676.57% | 57.81 490.31% | 57.69 0.21% | -31.40 154.43% | -16.48 47.52% | |
graham number | 40.53 - | 99.93 146.57% | 466.50 366.85% | 329.94 29.27% | 129.35 60.80% | 59.74 53.82% | |
income quality | 0.56 - | 0.78 38.54% | 0.32 59.18% | 0.79 148.88% | 0.68 13.91% | 1.01 48.19% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -5.03 - | -164.68 3,175.99% | -5.82K 3,432.36% | -2.11K 63.74% | -186.87 91.14% | 10.77 105.76% | |
interest debt per share | 5.38 - | 0.17 96.76% | 3.14 1,703.58% | 1.23 60.92% | 17.59 1,334.31% | 12.47 29.08% | |
inventory turnover | |||||||
invested capital | 0.04 - | 0.02 59.61% | -1.63 9,895.40% | -1.70 4.57% | |||
market cap | 40.63M - | 44.62M 9.82% | 38.16M 14.46% | 17.47M 54.22% | 2.96M 83.07% | 954.94K 67.70% | |
net current asset value | -50.50K - | 1.37M 2,806.34% | 9.27M 578.40% | 23.66M 155.18% | -16.05M 167.85% | -16.86M 5.02% | |
net debt to ebitda | 0.12 - | 0.53 330.36% | 0.51 4.41% | 1.00 97.12% | -0.30 129.63% | -0.62 107.85% | |
net income per share | -32.40 - | -29.00 10.50% | -127.86 340.88% | -67.40 47.28% | -70.12 4.03% | -19.09 72.78% | |
operating cash flow per share | -18.28 - | -22.53 23.25% | -40.79 81.04% | -53.39 30.89% | -43.61 18.33% | -19.34 55.66% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -4.36 - | -1.41 67.54% | -1.50 5.87% | -0.83 44.23% | -3.19 282.16% | -1.72 46.04% | |
revenue per share | |||||||
roe | -14.38 - | -1.90 86.82% | -1.69 10.82% | -0.94 44.44% | 6.61 804.11% | 2.30 65.26% | |
roic | -12.00 - | -1.88 84.30% | -1.62 13.84% | -0.93 42.76% | -5.93 538.69% | -2.50 57.80% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | 2.25 - | 15.30 579.27% | 75.65 394.35% | 71.78 5.11% | -10.60 114.77% | -8.31 21.64% | |
stock based compensation to revenue | |||||||
tangible asset value | 265.30K - | 1.98M 645.95% | 11.36M 474.13% | 27.32M 140.45% | -5.77M 121.14% | -9.12M 57.94% | |
tangible book value per share | 2.25 - | 15.30 579.27% | 75.65 394.35% | 71.78 5.11% | -10.60 114.77% | -8.31 21.64% | |
working capital | -50.50K - | 1.37M 2,806.34% | 9.27M 578.40% | 23.66M 155.18% | -11.59M 149.00% | -15.95M 37.55% |
All numbers in USD (except ratios and percentages)